Aurinia Pharma appoints Charles Rowland as CEO
Mr. Rowland has more than 30 years of experience in pharmaceutical operations, strategic value creation as well as financial management.
Mr. Rowland served as the Vice President and Chief Financial Officer of ViroPharma Incorporated until it was acquired by Shire plc.
Prior to joining ViroPharma in 2008, Mr. Rowland held a number of leadership positions at several biotechnology and pharmaceutical companies, most recently as interim Co-Chief Executive Officer and Executive Vice President and Chief Financial Officer for Endo Pharmaceuticals where he served from 2006 to 2008.
Mr. Rowland previously held positions of increasing responsibility at Biovail Corporation, Breakaway Technologies, Inc., Pharmacia Corporation, Novartis AG and Bristol-Myers Squibb. ■